1 min read
IDEXX Q3 Estimate Points to $1.19 Billion in Revenue Ahead of Report
The consensus earnings estimate is $3.71 per share, up 15.2% year over year; revenue is estimated to rise 8.2%.

IDEXX Laboratories (IDXX) is scheduled to report third-quarter results before market open Monday, Nov. 2, with consensus estimates pointing to year-over-year gains in revenue and earnings per share.
The consensus earnings estimate is $3.71 per share, 15.2% above the year-earlier level. Revenue is estimated at $1.19 billion, an 8.2% increase.